Human Papillomavirus: Challenges and Opportunities for the Control of Cervical Cancer

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses

(2022) Laila Sara Arroyo Mühr et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples

(2022) Alice Avian et al.   Journal of Translational Medicine

Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis

(2022) Tiwabwork Tekalign et al.   PLoS One

Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood

(2022) Sara Naseri et al.   OBSTETRICS AND GYNECOLOGY

Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America

(2022) Rita Mariel Correa et al.   PLoS One

Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications

(2022) Rosario Castro-Oropeza et al.   Frontiers in Genetics

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study

(2022) Laila Sara Arroyo Mühr et al.   JOURNAL OF CLINICAL VIROLOGY

Long-read sequencing reveals oncogenic mechanism of HPV-human fusion transcripts in cervical cancer

(2022) Min Liu et al.   Translational Research

Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance

(2022) Ankur Chakravarthy et al.   Nature Communications

Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment

(2022) Guanghui Song et al.   Frontiers in Public Health

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data

(2021) Qihang Zhong et al.   Journal of Translational Medicine

Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol

(2021) Severien Van Keer et al.   GYNECOLOGIC ONCOLOGY

Beta-Genus Human Papillomavirus 8 E6 Destabilizes the Host Genome by Promoting p300 Degradation

(2021) Dalton Dacus et al.   Viruses-Basel

The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis

(2021) Om Basukala et al.   Viruses-Basel

Multiple Human Papilloma Virus (HPV) Infections Are Associated with HSIL and Persistent HPV Infection Status in Korean Patients

(2021) Moonsik Kim et al.   Viruses-Basel

HPV DeepSeq: An Ultra-Fast Method of NGS Data Analysis and Visualization Using Automated Workflows and a Customized Papillomavirus Database in CLC Genomics Workbench

(2021) Jane Shen-Gunther et al.   Pathogens

Human papillomavirus E6 and E7: What remains?

(2021) Arushi Vats et al.   Tumour Virus Research

Comparative performance of the human papillomavirus test and cytology for primary screening for high‐grade cervical intraepithelial neoplasia at the population level

(2021) Erika Hurtado‐Salgado et al.   INTERNATIONAL JOURNAL OF CANCER

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

(2021) Partha Basu et al.   LANCET ONCOLOGY

Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities

(2021) Nicolas Wentzensen et al.   PREVENTIVE MEDICINE

Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial

(2021) Ruanne V. Barnabas et al.   Trials

Discovery of novel fish papillomaviruses: From the Antarctic to the commercial fish market

(2021) Simona Kraberger et al.   VIROLOGY

Prevalence, characteristics, and distribution of HPV genotypes in women from Zhejiang Province, 2016–2020

(2021) Xiaotian Yan et al.   Virology Journal

Machine learning prediction of antiviral-HPV protein interactions for anti-HPV pharmacotherapy

(2021) Hui-Heng Lin et al.   Scientific Reports

Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy

(2020) Alexander C. Cohen et al.   DRUGS

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries

(2020) Marc Brisson et al.   LANCET

The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity

(2020) Madleen Orumaa et al.   VACCINE

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy

(2020) Asmita Pal et al.   Frontiers in Microbiology

Commercially available molecular tests for human papillomaviruses: a global overview

(2020) M. Poljak et al.   CLINICAL MICROBIOLOGY AND INFECTION

FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort

(2020) F.J. Vink et al.   CLINICAL MICROBIOLOGY AND INFECTION

Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening

(2020) Eliane Rohner et al.   JOURNAL OF WOMENS HEALTH

HPV‐related methylation‐based reclassification and risk stratification of cervical cancer

(2020) Si Yang et al.   Molecular Oncology

Multiple HPV Infections and Viral Load Association in Persistent Cervical Lesions in Mexican Women

(2020) Mariel A. Oyervides-Muñoz et al.   Viruses-Basel

Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol

(2020) Maribel Almonte et al.   BMJ Open

Cervicovaginal microbiome and natural history of HPV in a longitudinal study

(2020) Mykhaylo Usyk et al.   PLoS Pathogens

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

(2020) Maria Kyrgiou et al.   BRITISH JOURNAL OF CANCER

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

(2020) Elizabeth T. H. Fontham et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project

(2020) Francesca Holme et al.   PREVENTIVE MEDICINE

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR

(2020) Laila Sara Arroyo Mühr et al.   BRITISH JOURNAL OF CANCER

Methylation markers FAM19A4 and miR124 ‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

(2020) Jesper Bonde et al.   INTERNATIONAL JOURNAL OF CANCER

Vaccination against HPV: boosting coverage and tackling misinformation

(2020) Janne Bigaard et al.   Molecular Oncology

Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries

(2020) Claudia Robles et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology

(2019) Mark H. Stoler et al.   GYNECOLOGIC ONCOLOGY

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

(2019) Nicole J Polman et al.   LANCET ONCOLOGY

Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study

(2019) Kate T Simms et al.   LANCET ONCOLOGY

Meta‐analysis of the accuracy of p16 or p16/Ki‐67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology

(2019) Eliana Peeters et al.   CANCER CYTOPATHOLOGY

Systemic therapy in cervical cancer: 30 years in review

(2019) Michalis Liontos et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Origin and evolution of papillomavirus (onco)genes and genomes

(2019) Anouk Willemsen et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus

(2019) Jiawei Zhao et al.   Nature Communications

Rural–Urban and Racial/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010–2014

(2019) Lulu Yu et al.   Preventing Chronic Disease

Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology

(2019) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study

(2019) Frederique J. Vink et al.   INTERNATIONAL JOURNAL OF CANCER

Education, income and occupation and their influence on the uptake of cervical cancer prevention strategies: A systematic review

(2019) Jessica Murfin et al.   JOURNAL OF CLINICAL NURSING

Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

(2019) Catherine de Martel et al.   Lancet Global Health

The Global Virome Project

(2018) Dennis Carroll et al.   SCIENCE

High Rate of Infection by Only Oncogenic Human Papillomavirus in Amerindians

(2018) Daniela Vargas-Robles et al.   mSphere

OUP accepted manuscript

(2018)   EUROPEAN JOURNAL OF PUBLIC HEALTH

Screening for Cervical Cancer

(2018) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples

(2018) M. Arbyn et al.   JOURNAL OF CLINICAL VIROLOGY

Molecular mechanisms of viral oncogenesis in humans

(2018) Nathan A. Krump et al.   NATURE REVIEWS MICROBIOLOGY

Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine – A randomized clinical trial

(2018) Vladimir Gilca et al.   VACCINE

Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans

(2018) Zigui Chen et al.   PLoS Pathogens

HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme

(2018) N.J. Polman et al.   PREVENTIVE MEDICINE

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial

(2017) Mahboobeh Safaeian et al.   JNCI-Journal of the National Cancer Institute

Integrated genomic and molecular characterization of cervical cancer

(2017)   NATURE

Co-carcinogenesis: Human Papillomaviruses, Coal Tar Derivatives, and Squamous Cell Cervical Cancer

(2017) Harry W. Haverkos et al.   Frontiers in Microbiology

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial

(2017) Mahboobeh Safaeian et al.   JNCI-Journal of the National Cancer Institute

Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix

(2016) Louise De Brot et al.   CANCER CYTOPATHOLOGY

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

(2016) Rengaswamy Sankaranarayanan et al.   LANCET ONCOLOGY

Transmission between Archaic and Modern Human Ancestors during the Evolution of the Oncogenic Human Papillomavirus 16

(2016) Ville N. Pimenoff et al.   MOLECULAR BIOLOGY AND EVOLUTION

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

(2016) Maaike G Dijkstra et al.   BMJ-British Medical Journal

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

(2016) Maaike G Dijkstra et al.   BMJ-British Medical Journal

Assessment of the Validity and Reproducibility of the Pap Smear in Mexico: Necessity of a Paradigm Shift

(2015) Elsa Yunes-Díaz et al.   ARCHIVES OF MEDICAL RESEARCH

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

(2015) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV-related cervical carcinogenesis

(2015) Ruiyang Zhang et al.   INTERNATIONAL JOURNAL OF CANCER

High-risk HPV testing in the management of atypical glandular cells: A systematic review and meta-analysis

(2015) Freija Verdoodt et al.   INTERNATIONAL JOURNAL OF CANCER

Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: Type-specific prevalence and HPV coinfections

(2015) Adriana Aguilar-Lemarroy et al.   JOURNAL OF MEDICAL VIROLOGY

Cancer incidence in indigenous people in Australia, New Zealand, Canada, and the USA: a comparative population-based study

(2015) Suzanne P Moore et al.   LANCET ONCOLOGY

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

(2015) Aimée R Kreimer et al.   LANCET ONCOLOGY

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

(2015) Elmar A. Joura et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effect of a booster dose of quadrivalent or bivalent HPV vaccine when administered to girls previously vaccinated with two doses of quadrivalent HPV vaccine

(2015) Vladimir Gilca et al.   Human Vaccines & Immunotherapeutics

Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes

(2015) Mauricio Hernández-Ávila et al.   Human Vaccines & Immunotherapeutics

Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial

(2015) Silvina Arrossi et al.   Lancet Global Health

Human Viral Oncogenesis: A Cancer Hallmarks Analysis

(2014) Enrique A. Mesri et al.   Cell Host & Microbe

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

(2014) Marc Arbyn et al.   LANCET ONCOLOGY

The Distribution of High-Risk Human Papillomaviruses Is Different in Young and Old Patients with Cervical Cancer

(2014) Mariano Guardado-Estrada et al.   PLoS One

Epigenetics and cervical cancer: from pathogenesis to therapy

(2014) Jinchuan Fang et al.   TUMOR BIOLOGY

Clinical Progression of High-Grade Cervical Intraepithelial Neoplasia: Estimating the Time to Preclinical Cervical Cancer From Doubly Censored National Registry Data

(2013) Margaretha A. Vink et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?

(2013) Susanne K. Kjær et al.   CANCER CAUSES & CONTROL

Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer

(2013) S.L. Sudenga et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

No Evidence for Synergy Between Human Papillomavirus Genotypes for the Risk of High-Grade Squamous Intraepithelial Lesions in a Large Population-Based Study

(2013) Nicolas Wentzensen et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Landscape of genomic alterations in cervical carcinomas

(2013) Akinyemi I. Ojesina et al.   NATURE

Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study

(2013) Unnop Jaisamrarn et al.   PLoS One

Evolution of the Papillomaviridae

(2013) Koenraad Van Doorslaer   VIROLOGY

Human papillomavirus genome variants

(2013) Robert D. Burk et al.   VIROLOGY

Oncogenic human papillomavirus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women

(2012) S. M. Leonard et al.   CARCINOGENESIS

Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16

(2012) Jacolien van der Marel et al.   INTERNATIONAL JOURNAL OF CANCER

Comprehensive Analysis of Host Cellular Interactions with Human Papillomavirus E6 Proteins Identifies New E6 Binding Partners and Reflects Viral Diversity

(2012) E. A. White et al.   JOURNAL OF VIROLOGY

Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses

(2012) E. A. White et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Type-Specific HPV Prevalence in Cervical Cancer and High-Grade Lesions in Latin America and the Caribbean: Systematic Review and Meta-Analysis

(2011) Agustín Ciapponi et al.   PLoS One

Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study

(2010) Koji Matsumoto et al.   INTERNATIONAL JOURNAL OF CANCER

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

(2010) Laia Bruni et al.   JOURNAL OF INFECTIOUS DISEASES

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

(2010) Hans-Ulrich Bernard et al.   VIROLOGY

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

(2009) Suzanne M. Garland et al.   JOURNAL OF INFECTIOUS DISEASES

Decreasing Cervical Cancer Mortality in Mexico: Effect of Papanicolaou Coverage, Birthrate, and the Importance of Diagnostic Validity of Cytology

(2008) E. Lazcano-Ponce et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION